New tools aim to spot nerve damage early in MS
NCT ID NCT03541226
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study followed 134 people with a first episode of neurological symptoms (clinically isolated syndrome) to develop better ways to detect nerve damage early. Researchers used MRI scans and eye exams to monitor changes over time. The goal was to help doctors decide when to start or adjust treatment for multiple sclerosis.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to monitor nerve damage early in multiple sclerosis, helping doctors adjust treatment sooner.
- What could go wrong
- This is an observational study, not a treatment trial. The tools developed may not prove useful in routine care or improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICALLY ISOLATED SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpital Roger Salengro, CHRU de Lille
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?